Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis

被引：11
作者：
Arita, Yoh [1 ]
Nakaoka, Yoshikazu [1 ,5 ]
Otsuki, Michio [2 ]
Higuchi, Kaori [1 ]
Hashimoto-Kataoka, Takahiro [1 ]
Yasui, Taku [1 ]
Masaki, Takeshi [1 ]
Ohtani, Tomohito [1 ]
Kishimoto, Tadamitsu [3 ]
Yamauchi-Takihara, Keiko [1 ]
Komuro, Issei [4 ]
Sakata, Yasushi [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan
[4] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1130033, Japan
[5] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 187卷
关键词：
Takayasu arteritis (TAK); Interleukin-6; Tocilizumab; Cytokine storm; Recurrence; THERAPY;
D O I：
10.1016/j.ijcard.2015.03.399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：319 / 321
页数：3
相关论文
共 50 条
  • [31] Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature
    Batu, Ezgi Deniz
    Sonmez, Hafize Emine
    Hazirolan, Tuncay
    Ozaltin, Fatih
    Bilginer, Yelda
    Ozen, Seza
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (04) : 529 - 535
  • [32] Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
    Unizony, S.
    Arias-Urdaneta, L.
    Miloslavsky, E.
    Arvikar, S.
    Khosroshahi, A.
    Keroack, B.
    Stone, J. R.
    Stone, J. H.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (11) : 1720 - 1729
  • [33] Modulation of Covid-19 cytokine storm by tocilizumab
    Boretti, Alberto
    Banik, Bimal
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 823 - 828
  • [34] Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis
    Lili Pan
    Juan Du
    Jiayi Liu
    Hua Liao
    Xiaoli Liu
    Xi Guo
    Jing Liang
    Hongya Han
    Lixia Yang
    Yujie Zhou
    Clinical Rheumatology, 2020, 39 : 2369 - 2378
  • [35] Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis
    Pan, Lili
    Du, Juan
    Liu, Jiayi
    Liao, Hua
    Liu, Xiaoli
    Guo, Xi
    Liang, Jing
    Han, Hongya
    Yang, Lixia
    Zhou, Yujie
    CLINICAL RHEUMATOLOGY, 2020, 39 (08) : 2369 - 2378
  • [36] Severe Renovascular Hypertension in a Patient With Takayasu Arteritis
    Seibel, Sabine
    Gaa, Jochen
    Kuechle, Claudius
    Frank, Helga
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (03) : 595 - 598
  • [37] Treatment of a Patient with a Pronounced Cytokine Storm in Severe COVID-19 Pneumonia using a Hemoadsorption in Combination with the Administration of tocilizumab
    Kornitzky, F. W.
    Langen, H. -J.
    Held, M.
    PNEUMOLOGIE, 2021, 75 (09): : 644 - 650
  • [38] Serum cytokine profiles in Takayasu's arteritis: search for biomarkers
    Alibaz-Oner, F.
    Yentur, S. P.
    Saruhan-Direskeneli, G.
    Direskeneli, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (02) : S32 - S35
  • [39] Anti-cytokine treatment for Takayasu arteritis: State of the art
    Tombetti, Enrico
    Di Chio, Maria Chiara
    Sartorelli, Silvia
    Bozzolo, Enrica
    Sabbadini, Maria Grazia
    Manfredi, Angelo A.
    Baldissera, Elena
    INTRACTABLE & RARE DISEASES RESEARCH, 2014, 3 (01) : 29 - 33
  • [40] Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
    Pelaia, Corrado
    Calabrese, Cecilia
    Garofalo, Eugenio
    Bruni, Andrea
    Vatrella, Alessandro
    Pelaia, Girolamo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 16
12345